Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
February 23, 2000Journal of Medicinal ChemistryOpen Access

4-5-Methyl-3-phenylisoxazol-4-yl- benzenesulfonamide, Valdecoxib:  A Potent and Selective Inhibitor of COX-2

View Full Paper
Ask AI
Bookmark
Share

Authors

JTJohn J. TalleyMonsanto (United States)DBDavid BrownUniversity of Central FloridaJCJeffery S. CarterMonsanto (United States)

Discussion

Loading...

Member takes

Implication

Key Points

Key points are not available for this paper at this time.

Cite This Study

Talley et al. (2000) studied this question.

synapsesocial.com/papers/69d97a470d540cafc5835a4dhttps://doi.org/10.1021/jm990577v
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched 4 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1Synthesis and Biological Evaluation of the 1,5-Diarylpyrazole Class of Cyclooxygenase-2 Inhibitors: Identification of 4-[5-(4-Methylphenyl)-3- (trifluoromethyl)-1 H -pyrazol-1-yl]benzenesulfonamide (SC-58635, Celecoxib)1997 · 1,970 citations
  2. 2Selective regulation of cellular cyclooxygenase by dexamethasone and endotoxin in mice.1990 · 398 citations
  3. 3Isolation and characterization of the complementary DNA for sheep seminal vesicle prostaglandin endoperoxide synthase (cyclooxygenase).1988 · 431 citations
  4. 4Primary structure of prostaglandin G/H synthase from sheep vesicular gland determined from the complementary DNA sequence.1988 · 597 citations